Adaptive Biotechnologies (ADPT) Beats Q4 Earnings Estimates by $0.10

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $-0.09, beating the consensus estimate of $-0.19 by $0.10 per share. Revenue came in at $71.7M, beating the estimate of $60.9M.

Adaptive Biotechnologies's stock moved following the earnings release. The stock currently trades at $15.77 with a market capitalization of $2.4B.